Drugs / AIDSVAX B/E
re-read 2 minutes ago

AIDSVAX B/E

Developed for
HIV infectious disease
Investigated by
VaxGen

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00002402 HIV infectious disease VaxGen Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as AIDSVAX B/E “Arm B: Patients receive AIDSVAX B/E (MN rgp120/HIV-1 plus A244 rgp120/HIV-1) vaccine in alum adjuvant.” NCT00002402
Route Intramuscular “1 or 2 injections into the deltoid muscle” NCT00002402